4.4 Article

Mass spectrometry for the detection of bioterrorism agents: from environmental to clinical applications

Journal

JOURNAL OF MASS SPECTROMETRY
Volume 51, Issue 3, Pages 183-199

Publisher

WILEY
DOI: 10.1002/jms.3747

Keywords

biological weapons; mass spectrometry; detection; quantification; advanced MS technology

Funding

  1. joint ministerial program of R&D against CBRNE risks
  2. Commissariat a l'Energie Atomique et aux Energies Alternatives
  3. Agence Nationale de la Recherche (GEFREASE program) [ANR-11-SECU-0007 01]
  4. Agence Nationale de la Recherche (ANR) [ANR-11-SECU-0007] Funding Source: Agence Nationale de la Recherche (ANR)

Ask authors/readers for more resources

In the current context of international conflicts and localized terrorist actions, there is unfortunately a permanent threat of attacks with unconventional warfare agents. Among these, biological agents such as toxins, microorganisms, and viruses deserve particular attention owing to their ease of production and dissemination. Mass spectrometry (MS)-based techniques for the detection and quantification of biological agents have a decisive role to play for countermeasures in a scenario of biological attacks. The application of MS to every field of both organic and macromolecular species has in recent years been revolutionized by the development of soft ionization techniques (MALDI and ESI), and by the continuous development of MS technologies (high resolution, accurate mass HR/AM instruments, novel analyzers, hybrid configurations). New possibilities have emerged for exquisite specific and sensitive detection of biological warfare agents. MS-based strategies for clinical application can now address a wide range of analytical questions mainly including issues related to the complexity of biological samples and their available volume. Multiplexed toxin detection, discovery of new markers through omics approaches, and identification of untargeted microbiological or of novel molecular targets are examples of applications. In this paper, we will present these technological advances along with the novel perspectives offered by omics approaches to clinical detection and follow-up. Copyright (c) 2016 John Wiley & Sons, Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available